These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17006914)

  • 1. Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious.
    Ratziu V; Poynard T
    Hepatology; 2006 Oct; 44(4):802-5. PubMed ID: 17006914
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver in a developing country is responsible for significant liver disease.
    Duseja A; Sharma B; Kumar A; Kapil S; Das A; Dhiman RK; Chawla YK
    Hepatology; 2010 Dec; 52(6):2248-9. PubMed ID: 20725907
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma and NASH.
    Kudo M
    J Gastroenterol; 2004; 39(4):409-11. PubMed ID: 15168260
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?].
    Ratziu V; Le Calvez S; Bonyhay L; Taieb J; Poynard T
    Gastroenterol Clin Biol; 2003 Oct; 27(10):869-75. PubMed ID: 14631300
    [No Abstract]   [Full Text] [Related]  

  • 8. Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis.
    Ichikawa T; Yanagi K; Motoyoshi Y; Hamasaki K; Nakao K; Toriyama K; Eguchi K
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1865-6. PubMed ID: 17074033
    [No Abstract]   [Full Text] [Related]  

  • 9. Preface.
    Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):xiii-xiv. PubMed ID: 19818301
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary liver cancers with nonalcoholic steatohepatitis.
    Hashizume H; Sato K; Takagi H; Hirokawa T; Kojima A; Sohara N; Kakizaki S; Mochida Y; Shimura T; Sunose Y; Ohwada S; Mori M
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM; Gupte PA; de Vera ME; Ahmad J
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.
    Rubinstein E; Lavine JE; Schwimmer JB
    Semin Liver Dis; 2008 Nov; 28(4):380-5. PubMed ID: 18956294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
    Yasui K; Hashimoto E; Komorizono Y; Koike K; Arii S; Imai Y; Shima T; Kanbara Y; Saibara T; Mori T; Kawata S; Uto H; Takami S; Sumida Y; Takamura T; Kawanaka M; Okanoue T;
    Clin Gastroenterol Hepatol; 2011 May; 9(5):428-33; quiz e50. PubMed ID: 21320639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.
    Takamatsu S; Noguchi N; Kudoh A; Nakamura N; Kawamura T; Teramoto K; Igari T; Arii S
    Hepatogastroenterology; 2008; 55(82-83):609-14. PubMed ID: 18613418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?
    Anagnostopoulos GK; Arvanitidis D; Tsiakos S; Margantinis G; Grigoriadis K; Kostopoulos P
    J Clin Gastroenterol; 2003 Jul; 37(1):88-9. PubMed ID: 12811221
    [No Abstract]   [Full Text] [Related]  

  • 16. Obesity and hepatocellular carcinoma.
    Caldwell SH; Crespo DM; Kang HS; Al-Osaimi AM
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S97-103. PubMed ID: 15508109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and prognosis after curative therapy for hepatocellular carcinoma: alas, still grave for those who are hyperglycemic.
    Teoh NC; Fan JG
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1633-4. PubMed ID: 19120856
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis].
    Bencheqroun R; Duvoux C; Luciani A; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 2004 May; 28(5):497-9. PubMed ID: 15243330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and prognosis of liver changes associated with cholelithiasis.
    Machnik G
    Morphol Embryol (Bucur); 1979; 25(3):237-40. PubMed ID: 228185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.